Naga P. Chalasani, MBBS
David W. Crabb Professor of Gastroenterology and Hepatology
Rotary Building, Suite 225 702 Rotary Cir
Indianapolis, IN 46202-5175
Titles & Appointments
- Professor of Medicine
- Adjunct Professor of Cellular & Integrative Physiology
- Chief, Gastroenterology/Hepatology Division
Portal Vein Thrombosis Is a Risk Factor for Poor Early Outcomes After Liver Transplantation: Analysis of Risk Factors and Outcomes for Portal Vein Thrombosis in Waitlisted Patients.
Standard Definitions and Common Data Elements for Clinical Trials in Patients With Alcoholic Hepatitis: Recommendation From the NIAAA Alcoholic Hepatitis Consortia.
A comprehensive assessment of environmental exposures among 1000 North American patients with primary sclerosing cholangitis, with and without inflammatory bowel disease.
Under-reporting and Poor Adherence to Monitoring Guidelines for Severe Cases of Isoniazid Hepatotoxicity.
IL-12/Th1 and IL-23/Th17 biliary microenvironment in primary biliary cirrhosis: implications for therapy.
Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations.
Pioglitazone versus vitamin E versus placebo for the treatment of non-diabetic patients with non-alcoholic steatohepatitis: PIVENS trial design.
Altered first-pass effects in a liver transplant recipient explained intraindividual variation in calcineurin inhibitor concentrations: a case report.
Abnormal enhancing lesion of dentate nuclei causing neurologic symptoms induced by metronidazole toxicity.
Clinical utility of blood cultures in adult patients with community-acquired pneumonia without defined underlying risks.
American Board of Internal Medicine - Gastroenterology